MAPK3 and neoplasm: Moreover, microbiota-derived metabolites such as kynurenic acid, urolithin A and short-chain fatty acids (SCFAs) could suppress the phosphorylation of ERK1/2 to inhibit tumor progression (Yang et al., 2023).